GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress Nov. 30, 2023 4:30 PM ET Source: GeoVax, Inc.
GeoVax to Participate in Upcoming December Investor Events Nov. 29, 2023 9:00 AM ET Source: GeoVax, Inc.
BOTS, Inc. Embarks on Advanced AI Journey With License to Evaluate NVIDIA's Cutting-Edge Enterprise AI Software Nov. 29, 2023 2:00 AM ET Source: BOTS Inc
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress Nov. 28, 2023 9:00 AM ET Source: GeoVax, Inc.
Best CBD Oil Black Friday Sales & Cyber Monday Deals For 2023 Are Now Live Nov. 24, 2023 9:00 AM ET Source: AAXLL
Nano-sized Probes Reveal how Cellular Structure Responds to Pressure Nov. 20, 2023 11:08 PM ET Source: ACN Newswire
Machine Learning Techniques Improve X-ray Materials Analysis Nov. 17, 2023 7:52 AM ET Source: ACN Newswire
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula Nov. 16, 2023 8:30 AM ET Source: Bioadaptives.com
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results Nov. 14, 2023 5:13 PM ET Source: Sigyn Therapeutics, Inc.
Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023 Nov. 14, 2023 9:00 AM ET Source: GeoVax, Inc.
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update Nov. 8, 2023 4:00 PM ET Source: GeoVax, Inc.
Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption Nov. 8, 2023 8:00 AM ET Source: Aclarion, Inc.
Ladybug Charts Strategic Transition: Shifting Focus to Health and Wellness Sector Nov. 7, 2023 7:00 AM ET Source: Ladybug Resource Group
Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD Nov. 6, 2023 8:00 AM ET Source: Aclarion, Inc.
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily Jun. 29, 2023 8:07 AM ET Source: Small Caps Daily
